United Therapeutics Corporation Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate
United Therapeutics Corporation (UTHR) had Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate of 4.42% as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Compensation Related Costs › Retirement Benefits › Defined Benefit Plan › Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation
us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate · last filed 2026-02-25
- 2025-12-31: Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate 4.42%.
- 2024-12-31: Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate 5.22%.
- 2023-12-31: Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate 4.64%.
- 2022-12-31: Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate 4.95%.
| Period end | Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate |
|---|---|
| 2025-12-31 | 4.42% 10-K · filed 2026-02-25 |
| 2024-12-31 | 5.22% 10-K · filed 2026-02-25 |
| 2023-12-31 | 4.64% 10-K · filed 2025-02-26 |
| 2022-12-31 | 4.95% 10-K · filed 2024-02-21 |
| 2021-12-31 | 2.05% 10-K · filed 2023-02-22 |
| 2020-12-31 | 1.49% 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |